highly significantp = 0.029
At the conclusion of the trial (Week 12), the ANOVA revealed highly significant differences between groups ( p = 0.029), with BR25/2 + Xcc (59.06 ± 11.81%; 33.5% efficacy) consistently outperforming BR27/2 + Xcc and the chemical treatment, categorizing it in a distinct statistical group (‘b’).